MeiraGTx Holdings (MGTX) Net Cash Flow (2017 - 2025)
MeiraGTx Holdings' (MGTX) quarterly Net Cash Flow came in at $50.9 million in Q4 2025, up 351.21% YoY from $11.3 million in Q4 2024, and up 491.88% on a QoQ basis from -$13.0 million in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Net Cash Flow (2017 - 2025) Analysis & Trends
MeiraGTx Holdings (MGTX) has 9 years of Net Cash Flow data on file, last reported at $50.9 million in Q4 2025.
- Quarterly Net Cash Flow rose 351.21% year-over-year to $50.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$38.2 million (down 44.23% YoY) and the FY2025 annual result came in at -$38.2 million, down 44.23% from the prior year.
- Net Cash Flow climbed to $50.9 million in Q4 2025, from -$13.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $64.3 million in Q4 2023 to a low of -$47.2 million in Q1 2023.
- A 5-year average of -$7.3 million and a median of -$16.1 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow surged 86848.65% — and 2025, when it slumped 244.83%.
- Tracing MGTX's Net Cash Flow over 5 years: stood at -$5.2 million in 2021, then surged by 101.41% to $74000.0 in 2022, then surged by 86848.65% to $64.3 million in 2023, then tumbled by 131.47% to -$20.2 million in 2024, then jumped by 351.21% to $50.9 million in 2025.
- The last three Net Cash Flow figures came in at $50.9 million (Q4 2025), -$13.0 million (Q3 2025), and -$39.3 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -183.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 374.50 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 407.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -496,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 225.59 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -37.14 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 50.84 Mn |
| Sep 30, 2025 | -12.99 Mn |
| Jun 30, 2025 | -39.26 Mn |
| Mar 31, 2025 | -36.83 Mn |
| Dec 31, 2024 | -20.25 Mn |
| Sep 30, 2024 | 23.62 Mn |
| Jun 30, 2024 | -19.18 Mn |
| Mar 31, 2024 | -10.67 Mn |
| Dec 31, 2023 | 64.34 Mn |
| Sep 30, 2023 | -28.38 Mn |
| Jun 30, 2023 | 23.96 Mn |
| Mar 31, 2023 | -47.23 Mn |
| Dec 31, 2022 | 74,000.00 |
| Sep 30, 2022 | 42.21 Mn |
| Jun 30, 2022 | -41.81 Mn |
| Mar 31, 2022 | -23.34 Mn |
| Dec 31, 2021 | -5.25 Mn |
| Sep 30, 2021 | -29.03 Mn |
| Jun 30, 2021 | -26.61 Mn |
| Mar 31, 2021 | -9.65 Mn |